Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Haleon Plc (HLN)

Haleon Plc (HLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 42,505,540
  • Shares Outstanding, K 4,526,681
  • Annual Sales, $ 14,059 M
  • Annual Income, $ 1,305 M
  • EBIT $ 1,748 M
  • EBITDA $ 2,132 M
  • 60-Month Beta 0.30
  • Price/Sales 3.00
  • Price/Cash Flow 25.45
  • Price/Book 2.02

Options Overview Details

View History
  • Implied Volatility 33.61% ( -2.97%)
  • Historical Volatility 14.56%
  • IV Percentile 46%
  • IV Rank 23.49%
  • IV High 108.59% on 08/05/24
  • IV Low 10.60% on 11/20/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 309
  • Volume Avg (30-Day) 279
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 5,741
  • Open Int (30-Day) 5,039

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.00
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.10 +3.57%
on 11/13/24
10.05 -6.22%
on 10/21/24
-0.66 (-6.59%)
since 10/18/24
3-Month
9.10 +3.57%
on 11/13/24
10.80 -12.73%
on 09/27/24
-0.26 (-2.63%)
since 08/16/24
52-Week
7.89 +19.46%
on 03/18/24
10.80 -12.73%
on 09/27/24
+1.18 (+14.24%)
since 11/17/23

Most Recent Stories

More News
The Hidden Power Of Spinoffs: Why They Continue To Outperform

CVS just announced it was considering a breakup. Why is that important? Spinoffs are one of the best-kept investment secrets, despite the fact that many investors typically disregard them and frequently...

PYPL : 84.80 (-1.20%)
CVS : 55.97 (+5.23%)
MDLZ : 63.98 (-0.79%)
TRIP : 13.79 (-1.08%)
COP : 114.10 (+1.58%)
KHC : 31.15 (+0.03%)
EXPE : 180.78 (-0.31%)
HLN : 9.42 (+0.32%)
PFE : 24.90 (+0.40%)
PSX : 131.58 (+1.40%)
EBAY : 61.36 (-0.11%)
VTRS : 13.01 (+1.40%)
4 Reasons Pfizer Could Be a Value Play You Can't Miss

Pfizer Inc. (NYSE: PFE) hit its peak during the COVID-19 pandemic when its vaccines developed with BioNTech SE (NASDAQ: BNTX) sent shares surging up to $61.71

HLN : 9.42 (+0.32%)
PFE : 24.90 (+0.40%)
BNTX : 101.67 (+1.96%)
You Can Stop Looking, Here's the Perfect Stock for the Current Market

While technology stocks continue to struggle, stocks in the lucrative over-the-counter healthcare products sector are thriving. One prominent such name is Haleon. Its stock has jumped more than 22% over...

GSK : 33.77 (+1.26%)
HLN : 9.42 (+0.32%)
PFE : 24.90 (+0.40%)
JNJ : 154.58 (+0.38%)
KVUE : 23.83 (+0.04%)
SNY : 48.62 (+1.36%)
GSK Stock Gains 18.5% Year to Date: Time to Buy, Sell or Hold?

GSK GSK  stock has risen 18.5% so far this year compared with an increase of 27.1% for the industry. The stock has also been consistently trading above its 50-day and 200-day moving averages since mid-August.GSK...

GSK : 33.77 (+1.26%)
NVO : 99.74 (-1.97%)
LLY : 724.18 (-2.95%)
HLN : 9.42 (+0.32%)
1 Pharma Stock to Buy Near 52-Week Highs

GSK's stock has been a poor performer for years. But recently, the pharma stock keeps setting new 52-week highs, thanks to its blockbuster vaccines.

GSK : 33.77 (+1.26%)
HLN : 9.42 (+0.32%)
1 Pharma Stock to Buy on Strong Vaccine Growth Potential

Unlike many of its peers, GSK just reported a big year-over-year jump in vaccine sales - and there's more growth to come, as the pharmaceutical company expands both its pipeline and the geographical reach...

MRNA : 39.69 (+7.71%)
GSK : 33.77 (+1.26%)
HLN : 9.42 (+0.32%)
CVS : 55.97 (+5.23%)
An Under the Radar Healthcare Stock to Add to Your Portfolio

The era of the giant pharmaceutical conglomerate is coming to a close, but consumer-focused Haleon stock looks set to deliver healthy returns through long-term economic cycles.

HLN : 9.42 (+0.32%)
GSK : 33.77 (+1.26%)
PFE : 24.90 (+0.40%)
NVS : 103.21 (+0.15%)
Is GSK Stock Worth Buying Right Now?

GSK stock could be a bargain.

HLN : 9.42 (+0.32%)
GSK : 33.77 (+1.26%)
Voltaren Partners with Fitness Instructor and TV Personality Amanda Kloots to Help Caregivers Discover the Joy of Movement

/PRNewswire/ -- More than 53 million Americans provide care to family members or loved ones,1 but an overwhelming 4 out of 5 Americans say that pain has...

HLN : 9.42 (+0.32%)
Stocks Climb Before the Open as Investors Weigh Economic Outlook, U.S. JOLTs Report in Focus

June S&P 500 futures (ESM23) are up +0.29%, and June Nasdaq 100 E-Mini futures (NQM23) are up +0.61% this morning after three major U.S. benchmark indices finished the regular session mixed as weaker-than-expected...

ESM23 : 4,453.35s (+0.61%)
NQM23 : 15,316.61s (+0.85%)
TSLA : 334.82 (+4.40%)
VORB : 0.0769 (-34.83%)
OKYO.LN : 1.400 (-24.32%)
BFLY : 2.65 (+12.77%)
AMC : 4.39 (-2.01%)
ONCT : 1.1000 (-3.51%)
EVO : 5.53 (+1.65%)
HLN : 9.42 (+0.32%)
CRBG : 30.58 (+0.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Haleon plc engages in the research and development, manufacture and sale of various consumer healthcare products principally in North America, Europe, the Middle East, Africa, Latin America and the Asia Pacific. It provides therapeutic oral health, pain relief, respiratory health, digestive health and...

See More

Key Turning Points

3rd Resistance Point 9.49
2nd Resistance Point 9.45
1st Resistance Point 9.42
Last Price 9.42
1st Support Level 9.35
2nd Support Level 9.31
3rd Support Level 9.28

See More

52-Week High 10.80
Fibonacci 61.8% 9.69
Last Price 9.42
Fibonacci 50% 9.35
Fibonacci 38.2% 9.00
52-Week Low 7.89

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar